Literature DB >> 15866503

A gel filtration assay to determine glycogen synthase activity.

Andreas Niederwanger1, Michael Kranebitter, Andreas Ritsch, Josef R Patsch, Michael T Pedrini.   

Abstract

We developed a gel filtration assay for the determination of glycogen synthase activity in cultured cells or tissue homogenates. Compared to the commonly used filter paper assay, the gel filtration assay resulted in a more than 5-fold reduction of background levels leading to an--at least--twofold increase in precision. These benefits allow the gel filtration method to detect differences of +/-5% in enzyme activity out of 300 microg total cell protein. In addition to high precision and sensitivity, the method's additional salient advantages include lesser expenditure of time and labour and reduced exposure time of the personnel to radioactivity.

Mesh:

Substances:

Year:  2005        PMID: 15866503     DOI: 10.1016/j.jchromb.2005.02.019

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Deficiency of a glycogen synthase-associated protein, Epm2aip1, causes decreased glycogen synthesis and hepatic insulin resistance.

Authors:  Julie Turnbull; Erica Tiberia; Sandra Pereira; Xiaochu Zhao; Nela Pencea; Anne L Wheeler; Wen Qin Yu; Alexander Ivovic; Taline Naranian; Nyrie Israelian; Arman Draginov; Mark Piliguian; Paul W Frankland; Peixiang Wang; Cameron A Ackerley; Adria Giacca; Berge A Minassian
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

2.  Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake.

Authors:  Tobias Tatarczyk; Christian Ciardi; Andreas Niederwanger; Michael Kranebitter; Josef R Patsch; Michael T Pedrini
Journal:  Mol Cell Endocrinol       Date:  2011-06-15       Impact factor: 4.102

3.  Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease.

Authors:  Nicholas P Clayton; Carol A Nelson; Timothy Weeden; Kristin M Taylor; Rodney J Moreland; Ronald K Scheule; Lucy Phillips; Andrew J Leger; Seng H Cheng; Bruce M Wentworth
Journal:  Mol Ther Nucleic Acids       Date:  2014-10-28       Impact factor: 10.183

4.  Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease.

Authors:  Kristin M Taylor; Elizabeth Meyers; Michael Phipps; Priya S Kishnani; Seng H Cheng; Ronald K Scheule; Rodney J Moreland
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.